PMGC Holdings ELAB
NASDAQ ELAB
$1.69 +0.11 (+6.96%)
At close: Nov 10, 2026 · 4:00 PM EST

PMGC Holdings (ELAB) EBT (2022 - 2026)

Updated

PMGC Holdings (ELAB) reported EBT of -$4.33 million for Q2 2026.

Analysis

PMGC Holdings (ELAB) EBT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, PMGC Holdings' EBT came in at -$13.11 million; for FY2025, it was -$7.75 million.

  • By year, EBT came in at -$4.02 million in FY2024, -$20,339 in FY2023 and -$1.79 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly EBT since Q3 2022.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$3.74 million (Q1 2026), -$2.67 million (Q4 2025) and -$2.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 34.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.83 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.96 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.06 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.39 Bn
10 PMGC Holdings 824,128.53 -47.54 Mn 385,691.00 -4.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.27 Mn
Mar 31, 2026 -3.18 Mn
Dec 31, 2025 -2.20 Mn
Sep 30, 2025 -2.37 Mn
Sep 30, 2024 -1.27 Mn
Jun 30, 2024 -1.43 Mn
Mar 31, 2024 -1.70 Mn
Dec 31, 2023 -3.76 Bn
Sep 30, 2023 -791,239.00
Jun 30, 2023 -1.06 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 -674.73 Mn
Sep 30, 2022 -469.32 Mn
API Access

PMGC Holdings EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ELAB&period=max&api_key=YOUR_API_KEY